Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone

The outcome of patients with multiple myeloma is dictated primarily by cytogenetic abnormalities and proliferative capacity of plasma cells. We studied the outcome after initial therapy with lenalidomide-dexamethasone among 100 newly diagnosed patients, risk-stratified by genetic abnormalities and p...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Kapoor, Prashant, Kumar, Shaji, Fonseca, Rafael, Lacy, Martha Q., Witzig, Thomas E., Hayman, Suzanne R., Dispenzieri, Angela, Buadi, Francis, Bergsagel, P. Leif, Gertz, Morie A., Dalton, Robert J., Mikhael, Joseph R., Dingli, David, Reeder, Craig B., Lust, John A., Russell, Stephen J., Roy, Vivek, Zeldenrust, Steven R., Stewart, A. Keith, Kyle, Robert A., Greipp, Philip R., Rajkumar, S. Vincent
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Hematology 2009
Ämnen:
Clinical Trials and Observations
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2713462/
https://ncbi.nlm.nih.gov/pubmed/19324902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-01-202010
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk